Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ)
CNY 13.93
(-0.5%)
CNY 13.93
(-0.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.11 Billion | 2.49 Billion | 1.79 Billion | 1.03 Billion | 982.92 Million | 635.77 Million |
| Net Income | 549.44 Million | 1.01 Billion | 917.2 Million | 789.16 Million | 603.31 Million | 519.77 Million |
| Depreciation & Amortization | 1.33 Billion | 1 Billion | 1.08 Billion | 79.78 Million | 73.42 Million | 74.35 Million |
| Deferred income taxes | 5.34 Million | -35.14 Million | -27.28 Million | -23.42 Million | 3.4 Million | 16.07 Million |
| Stock-based compensation | 3.99 Million | 14.23 Million | 40.4 Million | 32.38 Million | - | - |
| Change in working capital | -127.67 Million | -9.72 Million | -603.9 Million | 30.58 Million | 114.05 Million | -49.09 Million |
| Other non-cash items | 3.11 Billion | 514.12 Million | 377.48 Million | 124.86 Million | 192.11 Million | 90.74 Million |
| Investing Cash Flow | -543.06 Million | -221.7 Million | 131.66 Million | -924.72 Million | -556.84 Million | -894.26 Million |
| Investments in PPE | -253.46 Million | -348.98 Million | -391.62 Million | -280.17 Million | -206.86 Million | -156.02 Million |
| Acquisitions | -16.37 Million | -4.7 Million | -65.08 Million | 3.41 Million | 1.37 Million | -11.61 Million |
| Investment purchases | - | -980.51 Million | -1.97 Billion | -5.19 Billion | -3.32 Billion | -3.01 Billion |
| Sales/Maturities of investments | 1.69 Million | 1.2 Billion | 2.9 Billion | 4.72 Billion | 3.02 Billion | 2.35 Billion |
| Other Investing Activities | -273.22 Million | -94.73 Million | -336.9 Million | -181.54 Million | -52.65 Million | -69.29 Million |
| Financing Cash Flow | -1.44 Billion | -1.07 Billion | -1.3 Billion | -48.4 Million | -403.31 Million | -720.39 Million |
| Debt repayment | -35.55 Million | -207.94 Million | -137.1 Million | -51.05 Million | -800 Million | -514.03 Million |
| Dividends payments | -238.4 Million | -178.85 Million | -178.85 Million | -170.33 Million | -170.33 Million | -211.6 Million |
| Common Stock Repurchased | -343.44 Thousand | -2.04 Million | -104.2 Thousand | - | - | - |
| Common Stock Issuance | - | 2.04 Million | 104.19 Thousand | - | - | - |
| Other Financing Activities | -39.46 Million | -678.61 Million | -986.79 Million | 177.63 Million | 596.93 Million | 5.25 Million |
| Accounts receivables | 407.32 Million | -765.82 Million | -739.71 Million | -279.4 Million | 40.75 Million | -31.23 Million |
| Accounts payables | 90.47 Million | 1.02 Billion | 1.39 Billion | 570.5 Million | 275.97 Million | 195.82 Million |
| Inventory | -589.79 Million | -234.88 Million | -1.23 Billion | -237.09 Million | -206.07 Million | -229.76 Million |
| Other working capital | -35.69 Million | -35.14 Million | -27.28 Million | -23.42 Million | 3.4 Million | 180.66 Million |
| Cash at beginning of period | 3.51 Billion | 1.66 Billion | 1.04 Billion | 983.44 Million | 960.61 Million | 1.93 Billion |
| Cash at end of period | 3.67 Billion | 2.85 Billion | 1.66 Billion | 1.04 Billion | 983.44 Million | 960.61 Million |
| Capital Expenditure | -253.46 Million | -348.98 Million | -391.62 Million | -280.17 Million | -206.86 Million | -156.02 Million |
| Effect of forex changes on cash | 209.44 Thousand | 339.57 Thousand | -55.09 Thousand | -198.61 Thousand | 64.07 Thousand | 520.54 Thousand |
| Net cash flow / Change in cash | 164 Million | 1.19 Billion | 618.47 Million | 60.02 Million | 22.83 Million | -978.36 Million |
| Free Cash Flow | 1.86 Billion | 2.14 Billion | 1.4 Billion | 753.18 Million | 776.06 Million | 479.74 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 10.59 Million | 39.98 Million | 241.91 Million | -136.47 Million | 549.44 Million | 181.34 Million |
| Depreciation & Amortization | - | 330.17 Million | 330.17 Million | 341.31 Million | 1.33 Billion | -571.49 Million |
| Deferred income taxes | - | - | - | - | 5.34 Million | 277.92 Million |
| Stock-based compensation | - | 99.24 Thousand | - | 3.99 Million | 3.99 Million | -3.78 Million |
| Change in working capital | - | -501.01 Million | - | -218.15 Million | -127.67 Million | 297.36 Million |
| Other non-cash items | 308.82 Million | 690.04 Million | 300.55 Million | 1.25 Billion | 3.11 Billion | 477.31 Million |
| Investing Cash Flow | -160.76 Million | -241.65 Million | 8.75 Million | -258.37 Million | -543.06 Million | -183.32 Million |
| Investments in PPE | -67.28 Million | -48.16 Million | -53.09 Million | -85.33 Million | -253.46 Million | -81.55 Million |
| Acquisitions | -8 Million | -60.21 Million | -3.9 Million | -48.35 Million | -16.37 Million | 26.65 Million |
| Investment purchases | -700 Thousand | -50 Thousand | -3.5 Million | 10.24 Million | - | -3.24 Million |
| Sales/Maturities of investments | - | - | 200 Million | 1.02 Million | 1.69 Million | -26.65 Million |
| Other Investing Activities | -84.77 Million | -133.22 Million | -130.73 Million | -134.93 Million | -273.22 Million | -98.51 Million |
| Financing Cash Flow | -460.26 Million | -596.47 Million | -258.09 Million | -343.51 Million | -1.44 Billion | -248.69 Million |
| Debt repayment | -25.95 Million | -954.74 Thousand | -50.25 Million | -78.21 Million | -35.55 Million | -4.99 Million |
| Dividends payments | - | -245.24 Million | -5.46 Million | -238.4 Million | -238.4 Million | -10.99 Million |
| Common Stock Repurchased | - | - | - | -343.44 Thousand | -343.44 Thousand | 3495.54 |
| Common Stock Issuance | - | - | - | - | - | -3495.54 |
| Other Financing Activities | -434.3 Million | 57.64 Million | -308.35 Million | 1.17 Billion | -39.46 Million | -232.7 Million |
| Accounts receivables | - | -303.47 Million | - | 407.32 Million | 407.32 Million | -78.46 Million |
| Accounts payables | - | - | - | - | 90.47 Million | 127.71 Million |
| Inventory | - | -121.7 Million | - | -589.79 Million | -589.79 Million | 375.82 Million |
| Other working capital | - | -75.82 Million | - | -35.69 Million | -35.69 Million | -127.71 Million |
| Cash at beginning of period | 3.6 Billion | 3.9 Billion | 3.67 Billion | 3.32 Billion | 3.51 Billion | 2.58 Billion |
| Cash at end of period | 3.23 Billion | 3.6 Billion | 3.9 Billion | 3.67 Billion | 3.67 Billion | 2.81 Billion |
| Capital Expenditure | -67.28 Million | -48.16 Million | -53.09 Million | -85.33 Million | -253.46 Million | -81.55 Million |
| Effect of forex changes on cash | - | - | - | -214.57 Thousand | 209.44 Thousand | -4369.16 |
| Net cash flow / Change in cash | -367.92 Million | -301.82 Million | 230.24 Million | 349.47 Million | 164 Million | 226.63 Million |
| Free Cash Flow | 252.13 Million | 351.69 Million | 489.37 Million | 690.32 Million | 1.86 Billion | 577.1 Million |
600109
TEMN
603596
AVH
600880
0JQR